Abbott LaboratoriesABT:NYQ

46.19
0.42 / 0.92%
4.09m
21.46%
0.6119
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Dec 19 2014 16:29 GMT.

Summary

Abbott Laboratories (ABT:NYQ) set a new 52-week high during today's trading session when it reached 46.45. Over this period, the share price is up 22.07%.

52-week range
Today
35.65
Jan 29 2014
46.45
Dec 19 2014
Markit short selling activity
Low
Medium
High
Open45.91
Day high46.45
Day low45.78
Bid46.19
Offer46.20
Previous close45.77
Average volume5.04m
Shares outstanding1.51bn
Free float1.50bn
P/E (TTM)41.93
Market cap68.92bn USD
EPS (TTM)1.09 USD
Annual div (TTM)0.96 USD
Annual div yield (TTM)2.10%
Div ex-dateOct 10 2014
Div pay-dateNov 15 2014
Next div ex-dateJan 13 2015
Next div pay-dateFeb 13 2015
As of Dec 19 2014 16:29 GMT.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Abbott Laboratories+5.72%+6.36%+13.07%+21.46%+80.98%
S&P 500 INDEX+2.94%+0.61%+5.01%+13.91%+86.96%
USA/HEALTH CARE+2.54%+3.02%+14.50%+22.49%--
USA/H CARE EQUIP&SUPPL+3.01%+4.11%+11.39%+21.81%--
Data delayed at least 15 minutes, as of Dec 19 2014 16:14 GMT.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.